Company Filing History:
Years Active: 2021-2025
Title: Marinus (Rien) Van Haperen: Innovator in Monoclonal Antibodies
Introduction
Marinus (Rien) Van Haperen is a notable inventor based in Prinsenbeek, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 2 patents, his work focuses on innovative treatments for various diseases.
Latest Patents
Van Haperen's latest patents include groundbreaking research on antibodies binding to CTLA-4. These patents disclose isolated monoclonal antibodies that comprise a CD152-binding domain, specifically targeting human CD152. The methods outlined in these patents provide new avenues for treating diseases, including cancers and autoimmune disorders.
Career Highlights
Currently, Van Haperen is associated with Harbour Biomed (Shanghai) Co., Ltd., where he continues to advance his research in antibody development. His work is pivotal in the ongoing quest for effective therapies in the medical field.
Collaborations
Some of his notable coworkers include Xin Gan and Yun He, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Marinus (Rien) Van Haperen stands out as an influential inventor in the biotechnology sector, with his innovative patents paving the way for new treatments. His dedication to advancing medical science through monoclonal antibodies is commendable.